These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
561 related articles for article (PubMed ID: 30952834)
1. B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2. Shi T; Ma Y; Cao L; Zhan S; Xu Y; Fu F; Liu C; Zhang G; Wang Z; Wang R; Lu H; Lu B; Chen W; Zhang X Cell Death Dis; 2019 Apr; 10(4):308. PubMed ID: 30952834 [TBL] [Abstract][Full Text] [Related]
2. PLOD2 promotes aerobic glycolysis and cell progression in colorectal cancer by upregulating HK2. Du W; Liu N; Zhang Y; Liu X; Yang Y; Chen W; He Y Biochem Cell Biol; 2020 Jun; 98(3):386-395. PubMed ID: 31742425 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA KCNQ1OT1 promotes colorectal carcinogenesis by enhancing aerobic glycolysis via hexokinase-2. Chen C; Wei M; Wang C; Sun D; Liu P; Zhong X; Yu W Aging (Albany NY); 2020 Jun; 12(12):11685-11697. PubMed ID: 32564010 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3. Zhang T; Jiang B; Zou ST; Liu F; Hua D World J Gastroenterol; 2015 Feb; 21(6):1804-13. PubMed ID: 25684945 [TBL] [Abstract][Full Text] [Related]
5. B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression. Wang R; Ma Y; Zhan S; Zhang G; Cao L; Zhang X; Shi T; Chen W Cell Death Dis; 2020 Jan; 11(1):55. PubMed ID: 31974361 [TBL] [Abstract][Full Text] [Related]
6. B7-H3 regulates KIF15-activated ERK1/2 pathway and contributes to radioresistance in colorectal cancer. Ma Y; Zhan S; Lu H; Wang R; Xu Y; Zhang G; Cao L; Shi T; Zhang X; Chen W Cell Death Dis; 2020 Oct; 11(10):824. PubMed ID: 33011740 [TBL] [Abstract][Full Text] [Related]
7. FOXE1 represses cell proliferation and Warburg effect by inhibiting HK2 in colorectal cancer. Dai W; Meng X; Mo S; Xiang W; Xu Y; Zhang L; Wang R; Li Q; Cai G Cell Commun Signal; 2020 Jan; 18(1):7. PubMed ID: 31918722 [TBL] [Abstract][Full Text] [Related]
8. The ubiquitin-like protein UBTD1 promotes colorectal cancer progression by stabilizing c-Myc to upregulate glycolysis. Zhao L; Yu N; Zhai Y; Yang Y; Wang Y; Yang Y; Gong Z; Zhang Y; Zhang X; Guo W Cell Death Dis; 2024 Jul; 15(7):502. PubMed ID: 39003255 [TBL] [Abstract][Full Text] [Related]
9. B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3. Lin L; Cao L; Liu Y; Wang K; Zhang X; Qin X; Zhao D; Hao J; Chang Y; Huang X; Liu B; Zhang J; Lu J; Ge Q Leukemia; 2019 Jun; 33(6):1475-1486. PubMed ID: 30573782 [TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV inhibits cell proliferation of colorectal cancer cell lines through down-regulation of B7-H3. Wang S; Mou J; Cui L; Wang X; Zhang Z Biomed Pharmacother; 2018 Jun; 102():1037-1044. PubMed ID: 29710520 [TBL] [Abstract][Full Text] [Related]
11. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2. He R; Liu H Gene; 2020 Jul; 747():144553. PubMed ID: 32165307 [TBL] [Abstract][Full Text] [Related]
12. [Expression characteristics and clinical significance of B7-H3 in colorectal cancer]. Shao Y; Shi T; Guo L; Chen W Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 May; 40(5):435-442. PubMed ID: 38790100 [TBL] [Abstract][Full Text] [Related]
13. B7-H3, Negatively Regulated by miR-128, Promotes Colorectal Cancer Cell Proliferation and Migration. Hu X; Xu M; Hu Y; Li N; Zhou L Cell Biochem Biophys; 2021 Jun; 79(2):397-405. PubMed ID: 33743142 [TBL] [Abstract][Full Text] [Related]
14. The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer. Jiang B; Zhang T; Liu F; Sun Z; Shi H; Hua D; Yang C Oncotarget; 2016 May; 7(22):31755-71. PubMed ID: 27145365 [TBL] [Abstract][Full Text] [Related]
15. Methylation-associated silencing of miR-9-1 promotes nasopharyngeal carcinoma progression and glycolysis via HK2. Xu QL; Luo Z; Zhang B; Qin GJ; Zhang RY; Kong XY; Tang HY; Jiang W Cancer Sci; 2021 Oct; 112(10):4127-4138. PubMed ID: 34382305 [TBL] [Abstract][Full Text] [Related]
16. Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer. Zhang B; Chan SH; Liu XQ; Shi YY; Dong ZX; Shao XR; Zheng LY; Mai ZY; Fang TL; Deng LZ; Zhou DS; Chen SN; Li M; Zhang XD J Cell Mol Med; 2021 Sep; 25(18):8836-8849. PubMed ID: 34378321 [TBL] [Abstract][Full Text] [Related]
17. m Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489 [TBL] [Abstract][Full Text] [Related]
18. BAG3 directly stabilizes Hexokinase 2 mRNA and promotes aerobic glycolysis in pancreatic cancer cells. An MX; Li S; Yao HB; Li C; Wang JM; Sun J; Li XY; Meng XN; Wang HQ J Cell Biol; 2017 Dec; 216(12):4091-4105. PubMed ID: 29114069 [TBL] [Abstract][Full Text] [Related]
19. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy. Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711 [TBL] [Abstract][Full Text] [Related]
20. Dicer mediating the expression of miR-143 and miR-155 regulates hexokinase II associated cellular response to hypoxia. Yao M; Wang X; Tang Y; Zhang W; Cui B; Liu Q; Xing L Am J Physiol Lung Cell Mol Physiol; 2014 Dec; 307(11):L829-37. PubMed ID: 25172909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]